I really wouldn't put Pfizer in the same group as Apple, Amazon, and the like. What makes those stocks really strong are the lack of scaling costs (meaning they can scale up easily), and strong network effects leading to high barriers of entry (no one can easily compete with them). Pfizer doesn't have any of these advantages, it's recent performance is largely driven by the covid pandemic - which is temporary by nature.
Missed Out on the FAANG Stocks? Consider Buying These PfANG Stocks Instead.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
